[Fetal MRI: indications, limits and dangers].

Gynecol Obstet Fertil

Service de Radiopédiatrie, Centre Hospitalier Universitaire de Rouen, 1 Rue de Germont, 76031 Rouen cedex, France.

Published: September 2007

Although prenatal sonography remains the primary imaging method for screening fetal anomalies, fetal MRI with ultrafast imaging technique is a complementary imaging method as soon as the second trimester. It allows better tissue contrast images than does US, a large field of view of the foetus and is not limited by large maternal body habitus and oligohydramnios, without any risk for the foetus. In the future, the development of new techniques (diffusion-weighted imaging, proton MR spectroscopy) and faster sequences will make it possible to widen the indications i.e. cardiac, functional renal and cerebral imaging.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gyobfe.2007.05.018DOI Listing

Publication Analysis

Top Keywords

imaging method
8
imaging
5
[fetal mri
4
mri indications
4
indications limits
4
limits dangers]
4
dangers] prenatal
4
prenatal sonography
4
sonography remains
4
remains primary
4

Similar Publications

Background: Clinical decision support systems leveraging artificial intelligence (AI) are increasingly integrated into health care practices, including pharmacy medication verification. Communicating uncertainty in an AI prediction is viewed as an important mechanism for boosting human collaboration and trust. Yet, little is known about the effects on human cognition as a result of interacting with such types of AI advice.

View Article and Find Full Text PDF

Background: Systemic lupus erythematosus (SLE) is characterized by a range of symptoms that often cluster together, impacting the quality of life (QoL) of affected individuals.

Objective: To delineate the composition of symptom clusters in patients with SLE and analyze their correlation with QoL, thus providing a basis for symptom management.

Methods: Using convenience sampling, 201 patients were recruited.

View Article and Find Full Text PDF

Application of artificial intelligence to ultrasound imaging for benign gynecological disorders: systematic review.

Ultrasound Obstet Gynecol

January 2025

Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.

Objective: Although artificial intelligence (AI) is increasingly being applied to ultrasound imaging in gynecology, efforts to synthesize the available evidence have been inadequate. The aim of this systematic review was to summarize and evaluate the literature on the role of AI applied to ultrasound imaging in benign gynecological disorders.

Methods: Web of Science, PubMed and Scopus databases were searched from inception until August 2024.

View Article and Find Full Text PDF

Minimally invasive biomarkers for triaging lung nodules-challenges and future perspectives.

Cancer Metastasis Rev

January 2025

Saliva and Liquid Biopsy Translational Laboratory, Institute for Biomedicine and Glycomics (IBG), Griffith University, Brisbane, 4111, Australia.

CT chest scans are commonly performed worldwide, either in routine clinical practice for a wide range of indications or as part of lung cancer screening programs. Many of these scans detect lung nodules, which are small, rounded opacities measuring 8-30 mm. While the concern about nodules is that they may represent early lung cancer, in screening programs, only 1% of such nodules turn out to be cancer.

View Article and Find Full Text PDF

Objectives: To compare six doses of intrapleural streptokinase (SK) vs. the conventional three doses in children with empyema.

Methods: In this randomized controlled trial, children with empyema received intrapleural streptokinase, either twice daily for 3 d (total 6 doses); or once daily for 3 d (total 3 doses).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!